Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1010 | Completion of survey after peak of pandemic Wiki | 1.00 |
| drug2628 | Norovirus Bivalent (GI.1 / GII.4) Vaccine（low） Wiki | 1.00 |
| drug2627 | Norovirus Bivalent (GI.1 / GII.4) Vaccine（high） Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D005759 | Gastroenteritis NIH | 0.71 |
| D017250 | Caliciviridae Infections NIH | 0.71 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The current COVID-19 pandemic has caused delays in initial or follow-up encounters between surgical patients and physicians. While this delay allows for resource allocation to those most severely affected by the pandemic, surgeons are faced with potential important delays in diagnosis and the expanding backlog of elective cases and initial evaluations. This project will assess surgeon and patient telemedicine perspectives. Pre-pandemic views on telemedicine among a cohort of surgeons will be obtained and compared to views at 3 months from the peak of the pandemic. Patients will be surveyed following telemedicine appointments with an anonymous questionnaire to learn about patient receptiveness to telemedicine. Barriers to implementation will be addressed throughout the duration of the study.
Description: Surgeons will take an anonymous survey early after the start of the study regarding perceptions to telemedicine and perceived barriers to implementation. Surgeons will be asked again after 3 months from the peak of the pandemic to take another survey to assess how the pandemic has changed perceptions to telemedicine and the observed barriers to implementation.
Measure: Evaluate surgeon perceptions to telemedicine and perceived barriers to implementation Time: 6 monthsDescription: Patients will take an optional anonymous survey at the end of each telemedicine encounter to assess patient perceptions to telemedicine and barriers to implementation.
Measure: Evaluate patient perceptions to telemedicine and perceived barriers to implementation Time: 6 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports